David Rikard Martinsson Holmdahl
Fondatore presso Redoxis AB
Posizioni attive di David Rikard Martinsson Holmdahl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Presidente | 01/01/2007 | - |
| Fondatore | 01/01/2007 | - | |
| Karolinska Institutet | Corporate Officer/Principal | 22/12/2009 | - |
| University of Turku | Corporate Officer/Principal | 26/07/2011 | - |
Storia della carriera di David Rikard Martinsson Holmdahl
Precedenti posizioni note di David Rikard Martinsson Holmdahl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Lund | Corporate Officer/Principal | 01/01/2007 | 01/01/2007 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Direttore/Membro del Consiglio | 28/12/2009 | - |
Statistiche
Distribuzione geografica
| Svezia | 5 |
| Finlandia | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chairman | 1 |
| Founder | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
